Skip to content
Screener

Azenta AZTA Multiomics — Depreciation Expense

Similar metrics at other companies

BioSig Technologies, Inc. logo
STEXDepreciation Expense
$3K
Skyline Champion logo
SKYDepreciation Expense
$9.34M+3.8%
Skyline Champion logo
SKYCorporate Or Other — Depreciation Expense
$146K-9.9%
Skyline Champion logo
SKYCanadian Factory Built Housing — Depreciation Expense
$409K-11.3%
Skyline Champion logo
SKYUS Factory Built Housing — Depreciation Expense
$8.79M+4.9%
The Cooper Companies, Inc. logo
COOCooperSurgical — Depreciation expense
$6.5M+10.2%

Other financials

Income statement

See full
Revenue$161.2M+12.0%
Gross profit$72.4M+9.0%
Operating income-$4.2M-126%
Net income$2.5M+105%
EPS (diluted)$0.05+105%

Balance sheet

See full
Cash & equivalents$70.8M
Total debt$54.0M
Total equity$1.5B-9.7%
Total assets$1.9B

Cash flow

See full
Operating cash flow$1.4M-94.4%
CapEx$6.6M-38.7%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.48B+15.1%
Enterprise value$1.46B
P/S2.4×+0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-20%+1.5pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-7.7%
Debt / equity
Current ratio2.5×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Azenta’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054295
MultiomicsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Nine Months Ended June 30, 2026Nine Months Ended June 30, 2025
Total revenue$72,889$66,235$203,811$196,054
Less: Adjusted cost of revenue38,97039,151115,648110,939
Less: Adjusted operating expenses34,26731,042102,94096,916
Adjusted operating loss$(348)$(3,958)$(14,777)$(11,801)
Other Information
Depreciation Expense$2,647$4,024$10,588$11,346

Item 1. Financial Statements

FAQ

What is Azenta's multiomics — depreciation expense?
Azenta (AZTA) reported multiomics — depreciation expense of $2.65M in Q2 2026.
How has Azenta's multiomics — depreciation expense changed year-over-year?
Azenta's multiomics — depreciation expense decreased by 34.2% year-over-year, from $4.02M to $2.65M.
What is the long-term trend for Azenta's multiomics — depreciation expense?
Over 2 years (2023 to 2025), Azenta's multiomics — depreciation expense has grown at a 3.6% compound annual growth rate (CAGR), from $14.21M to $15.25M.
What does multiomics — depreciation expense mean?
The systematic allocation of the cost of tangible assets used within the Multiomics segment over their estimated useful lives. This non-cash expense reflects the wear and tear or obsolescence of equipment and infrastructure necessary for genomic and multiomics operations. Tracking this helps investors understand the capital intensity and asset replacement requirements of the segment.

Ask your AI about Azenta's multiomics — depreciation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude